Publication | Open Access
<p>Longdaysin inhibits Wnt/&beta;-catenin signaling and exhibits antitumor activity against breast cancer</p>
24
Citations
17
References
2019
Year
Longdaysin is a novel inhibitor of the Wnt/β-catenin signaling pathway. It exerts antitumor effect through blocking CK1δ/ε-dependent Wnt signaling.
| Year | Citations | |
|---|---|---|
Page 1
Page 1